Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
9.25
+0.40 (4.52%)
Nov 6, 2026, 4:00 PM EST - Market closed
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $276.8 million as of November 6, 2026. It is the 18,416th most valuable company in the world and the 3,258th biggest in the United States. Its market cap has increased by 849.48% in one year.
Market Cap
276.80M
Enterprise Value
-7.67M
1-Year Change
849.48%
Global Rank
Country Rank
#3,258 United States
Category
ChartMarket Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $276.80M, an increase of 38.96%. That is a compound annual growth rate of 13.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 276.80M | 577.58% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 273.42M |
| Ocugen | 272.03M |
| vTv Therapeutics | 270.98M |
| Vogenx | 270.36M |
| Nautilus Biotechnology | 268.76M |
| ARS Pharmaceuticals | 267.51M |
| Arcturus Therapeutics Holdings | 267.18M |
| SAB Biotherapeutics | 266.59M |